Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by balainon Apr 07, 2017 12:28pm
271 Views
Post# 26092293

RE:RE:RE:RE:RE:RE:RE:NR!

RE:RE:RE:RE:RE:RE:RE:NR!Definitely news worthy. I understand not releasing when it's a $100k order, a $300K, or even a $1M order, but $9.5 million shows that there is a good business there. Where do we draw the line at what is news worthy or not? Not sure, but $9.5 is no doubt over that line by quite the margin :)

The deal with Shenzhen brought money into the bank account, which is terrific. But that deal was a deal between 2 business entities agreeing that if deals can be signed, one will make 75%, the other will make 25%. It's basically a deal agreeing that if we can make a deal, it will be good for everyone...lol

The markets will recognize when that deal is made. Not a deal agreeing that making a deal is good for business. I can't wait to see what the next news on that front brings. The stock price will in my opinion move positively on those news, but in the meantime, it seems like the old days of seeing the share price jump on positive news are over. The markets want to feel,see, and smell the money. If that doesn't work, then it will simply show that today's markets are totally disconnected from companies value, ans simply following the flavour of the day, for no apparent reason. The latter may actually be more lucratibve to bank and institutions trading the stocks daily  vs looking to find and hold valuable companies for the long term...

So hopefully, we see a nice rise in SP when deals are made to buy or partner Prometic's products and technology (PG, IVIG and 4050 are well positionned to generate revenues short to mid term). Someone mentionned Johnson and Johnson/band aids/ plasminogen combo, and that may very well be in the cards. We may be a bit far from seeing this as probably many more trials (and $$$) are going to be needed, but would/will definitiely be a game changer when it happens.

As always, fingers crossed for positive surprises as we get through 2017.

The market needs those to reward us...

balain
Bullboard Posts